Single versus multiple impulse control disorders in Parkinson’s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release

Journal of Neurology

Volumn 262, Issue 6, 2015, Pages 1504-1514

  Wu, Kit ^a   Politis, Marios ^a,d   O’Sullivan, Sean S ^a,b   Lawrence, Andrew D ^c   Warsi, Sarah ^a   Bose, Subrata ^a   Lees, Andrew J ^b   Piccini, Paola ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Addiction; Comorbidity; Impulse control disorders; Neuroimaging; Parkinson s disease; PET

Indexed keywords

RACLOPRIDE C 11; CARBON; RACLOPRIDE;

ADULT; ARTICLE; ASSOCIATION; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; IMPULSE CONTROL DISORDER; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REWARD; SELF EVALUATION; SENSATION SEEKING; UNIFIED PARKINSON DISEASE RATING SCALE; VENTRAL STRIATUM; ANALYSIS OF VARIANCE; COMPLICATION; CORPUS STRIATUM; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; DRUG EFFECTS; MIDDLE AGED; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; SCINTISCANNING;

ANALYSIS OF VARIANCE; CARBON ISOTOPES; CORPUS STRIATUM; CUES; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; RACLOPRIDE; REWARD;

EID: 84931006444     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7722-7     Document Type: Article

References (60)

1. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington
2. Weintraub D, Koester J, Potenza MN et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5):589–595. doi:10.1001/archneurol.2010.65 (published online first: Epub date)
3. Voon V, Sohr M, Lang AE et al (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69(6):986–996. doi:10.1002/ana.22356 (published online first: Epub date)
4. Grant JE, Kim SW (2003) Comorbidity of impulse control disorders in pathological gamblers. Acta Psychiatr Scand 108(3):203–207
5. Krueger RF, Bezdjian S (2009) Enhancing research and treatment of mental disorders with dimensional concepts: toward DSM-V and ICD-11. World psychiatry Off J World Psychiatr Assoc 8(1):3–6
6. Verhulst FC, van der Ende J (1993) “Comorbidity” in an epidemiological sample: a longitudinal perspective. J Child Psychol Psychiatry 34(5):767–783
7. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18(3):247–291
8. Joutsa J, Johansson J, Niemela S et al (2012) Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 60(4):1992–1999. doi:10.1016/j.neuroimage.2012.02.006 (published online first: Epub date)
9. Berridge KC (2012) From prediction error to incentive salience: mesolimbic computation of reward motivation. Eur J Neurosci 35(7):1124–1143. doi:10.1111/j.1460-9568.2012.07990.x (published online first: Epub date)
10. Nocjar C, Panksepp J (2002) Chronic intermittent amphetamine pretreatment enhances future appetitive behavior for drug- and natural-reward: interaction with environmental variables. Behav Brain Res 128(2):189–203
11. Piccini PP (2003) Dopamine transporter: basic aspects and neuroimaging. Mov Disord 18(Suppl 7):S3–S8. doi:10.1002/mds.10571 (published online first: Epub date)
12. Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184
13. Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64(8):1089–1096. doi:10.1001/archneur.64.8.1089 (published online first: Epub date)
14. McElroy SL, Keck PE Jr, Pope HG Jr et al (1994) Compulsive buying: a report of 20 cases. J Clin Psychiatry 55(6):242–248
15. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
16. O’Sullivan SS, Wu K, Politis M et al (2011) Cue-induced striatal dopamine release in Parkinson’s disease-associated impulsive-compulsive behaviours. Brain 134(Pt 4):969–978. doi:10.1093/brain/awr003 (published online first: Epub date)
17. Beck AT, Steer RA, Ball R et al (1996) Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 67(3):588–597. doi:10.1207/s15327752jpa6703_13 (published online first: Epub date)
18. Visser M, Leentjens AF, Marinus J et al (2006) Reliability and validity of the Beck depression inventory in patients with Parkinson’s disease. Mov Disord 21(5):668–672. doi:10.1002/mds.20792 (published online first: Epub date)
19. Stephenson MT, Hoyle RH, Palmgreen P et al (2003) Brief measures of sensation seeking for screening and large-scale surveys. Drug Alcohol Depend 72(3):279–286. doi:10.1016/j.drugalcdep.2003.08.003 (published online first: Epub date)
20. Saunders J, Aasland O, Babor T et al (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption-II. Addiction 88(6):791–804
21. Heatherton T, Kozlowski L, Frecker R et al (1993) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991(86):1119–1127
22. Evans AH, Katzenschlager R, Paviour D et al (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19(4):397–405. doi:10.1002/mds.20045 (published online first: Epub date)
23. Stebbins GT, Goetz CG (1998) Factor structure of the unified Parkinson’s disease rating scale: motor examination section. Mov Disord 13(4):633–636. doi:10.1002/mds.870130404 (published online first: Epub date)
24. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54(6):1063–1070
25. Crawford JR, Henry JD (2004) The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol 43(Pt 3):245–265. doi:10.1348/0144665031752934 (published online first: Epub date)
26. Carter BL, Tiffany ST (1999) Cue-reactivity and the future of addiction research. Addiction 94(3):349–351
27. Sodano R, Wulfert E (2010) Cue reactivity in active pathological, abstinent pathological, and regular gamblers. J Gambl Stud 26(1):53–65. doi:10.1007/s10899-009-9146-8 (published online first: Epub date)
28. Starcke K, Schlereth B, Domass D, Schöler T, Brand M (2013) Cue reactivity towards shopping cues in female participants. J Behav Addict 2:17–22
29. Sobik L, Hutchison K, Craighead L (2005) Cue-elicited craving for food: a fresh approach to the study of binge eating. Appetite 44(3):253–261. doi:10.1016/j.appet.2004.12.001 (published online first: Epub date)
30. Lang PJ, Bradley MM, Cuthbert BN (2008) International affective picture system (IAPS): affective ratings of pictures and instruction manual. Unversity of Florida, Gainsville
31. Mahler SV, de Wit H (2010) Cue-reactors: individual differences in cue-induced craving after food or smoking abstinence. PLoS One 5(11):e15475. doi:10.1371/journal.pone.0015475 (published online first: Epub date)
32. Brix G, Zaers J, Adam LE et al (1997) Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38(10):1614–1623
33. Duvernoy HM (1999) The human brain: surface, blood supply, and three-dimensional sectional anatomy. Springer Wien, New York
34. Ahsan RL, Allom R, Gousias IS et al (2007) Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus. Neuroimage 38(2):261–270. doi:10.1016/j.neuroimage.2007.06.004 (published online first: Epub date)
35. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4(3 Pt 1):153–158. doi:10.1006/nimg.1996.0066 (published online first: Epub date)
36. Gunn RN, Lammertsma AA, Hume SP et al (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6(4):279–287. doi:10.1006/nimg.1997.0303 (published online first: Epub date)
37. Watson D, Wiese D, Vaidya J et al (1999) The two general activation systems of affect: structural findings, evolutionary considerations, and psychobiological evidence. J Pers Soc Psychol 76:820–838
38. Laruelle M, Huang Y (2001) Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights. Q J Nucl Med 45(2):124–138
39. Steeves TD, Miyasaki J, Zurowski M et al (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132(Pt 5):1376–1385. doi:10.1093/brain/awp054 (published online first: Epub date)
40. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28(3):309–369
41. Evans AH, Pavese N, Lawrence AD et al (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59(5):852–858. doi:10.1002/ana.20822 (published online first: Epub date)
42. Holroyd KB, Adrover MF, Fuino RL et al (2014) Loss of feedback inhibition via D2 autoreceptors enhances acquisition of cocaine taking and reactivity to drug-paired cues. Neuropsychopharmacology. doi:10.1038/npp.2014.336 (published online first: Epub date)
43. Buckholtz JW, Treadway MT, Cowan RL et al (2010) Dopaminergic network differences in human impulsivity. Science 329(5991):532. doi:10.1126/science.1185778 (published online first: Epub date)
44. Ray NJ, Miyasaki JM, Zurowski M et al (2012) Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis 48(3):519–525. doi:10.1016/j.nbd.2012.06.021 (published online first: Epub date)
45. Lawrence AD, Brooks DJ, Whone AL (2013) Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson’s disease. Front Psychol 4:90. doi:10.3389/fpsyg.2013.00090 (published online first: Epub date)
46. Lawrence AD, Brooks DJ (2014) Ventral striatal dopamine synthesis capacity is associated with individual differences in behavioral disinhibition. Front Behav Neurosci 8:86. doi:10.3389/fnbeh.2014.00086 (published online first: Epub date)
47. Engber TM, Susel Z, Juncos JL et al (1989) Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists. Eur J Pharmacol 168(3):291–298
48. Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25–53. doi:10.1146/annurev.psych.54.101601.145237 (published online first: Epub date)
49. Zack M, Poulos CX (2004) Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 29(1):195–207. doi:10.1038/sj.npp.1300333 (published online first: Epub date)
50. Politis M, Loane C, Wu K et al (2013) Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson’s disease. Brain 136(Pt 2):400–411. doi:10.1093/brain/aws326 (published online first: Epub date)
51. Joutsa J, Martikainen K, Vahlberg T et al (2012) Impulse control disorders and depression in Finnish patients with Parkinson’s disease. Parkinsonism Relat Disord 18(2):155–160. doi:10.1016/j.parkreldis.2011.09.007 (published online first: Epub date)
52. Black DW, Moyer T (1998) Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 49(11):1434–1439
53. El-Guebaly N (1995) Substance use disorders and mental illness: the relevance of comorbidity. Can J Psychiatry 40(1):2–3
54. Ibanez A, de Perez CI, Fernandez-Piqueras J et al (2000) Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 5(1):105–109
55. Bondolfi G, Osiek C, Ferrero F (2000) Prevalence estimates of pathological gambling in Switzerland. Acta Psychiatr Scand 101(6):473–475
56. Yip SW, White MA, Grilo CM et al (2011) An exploratory study of clinical measures associated with subsyndromal pathological gambling in patients with binge eating disorder. J Gambl Stud 27(2):257–270. doi:10.1007/s10899-010-9207-z (published online first: Epub date)
57. Dalley JW, Roiser JP (2012) Dopamine, serotonin and impulsivity. Neuroscience 215:42–58. doi:10.1016/j.neuroscience.2012.03.065 (published online first: Epub date)
58. Carver CS, Johnson SL, Joormann J (2008) Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression. Psychol Bull 134(6):912–943. doi:10.1037/a0013740 (published online first: Epub date)
59. Callesen MB, Weintraub D, Damholdt MF et al (2013) Impulsive and compulsive behaviors among Danish patients with Parkinson’s disease: Prevalence, depression, and personality. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2013.09.006 (published online first: Epub date)
60. Munro CA, McCaul ME, Wong DF et al (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59(10):966–974. doi:10.1016/j.biopsych.2006.01.008 (published online first: Epub date)